XNYSAHR
Market cap4.34bUSD
Jan 08, Last price
28.33USD
1D
2.46%
1Q
17.07%
IPO
114.30%
Name
American Healthcare REIT Inc
Chart & Performance
Profile
Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value. The company benefits from a fully integrated management platform comprised of more than one hundred experienced and skilled professionals, many of whom have worked together since 2006 and have successfully invested in and managed healthcare real estate through multiple market cycles. The management team has a proven track record, deep industry relationships and unparalleled insight into each of the company's assets having built and nurtured the company's international portfolio since its original property acquisition in 2014. The strength of the management team, coupled with the quality of the assets, has American Healthcare REIT poised to capitalize on compelling growth driven by powerful demographic trends. With its 19 million-square-foot, 312-building portfolio of medical office buildings, senior housing communities, skilled nursing facilities and integrated senior health campuses diversified across 36 states and the United Kingdom, the tri-party transaction was a critical step in ideally positioning American Healthcare REIT for a future public listing or IPO on a national stock exchange at the most opportune time. By listing the company's shares on a national exchange, we believe the company will gain greater access to attractive capital that will fuel future growth, broaden our investor base and also provide liquidity to our fellow stockholders. American Healthcare REIT, Inc. operates as a subsidiary of Griffin Capital Company, LLC.
IPO date
Jan 17, 2023
Employees
Domiciled in
US
Incorporated in
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
Income | ||||||||
Revenues | 1,859,143 12.96% | 1,645,771 28.25% | ||||||
Cost of revenue | 1,613,090 | 1,835,099 | ||||||
Unusual Expense (Income) | ||||||||
NOPBT | 246,053 | (189,328) | ||||||
NOPBT Margin | 13.23% | |||||||
Operating Taxes | 663 | (188,828) | ||||||
Tax Rate | 0.27% | |||||||
NOPAT | 245,390 | (500) | ||||||
Net income | (71,469) -1.82% | (72,797) 39.16% | ||||||
Dividends | (76,284) | (51,122) | ||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | (469) | (20,699) | ||||||
BB yield | ||||||||
Debt | ||||||||
Debt current | 846,770 | 2,001,816 | ||||||
Long-term debt | 2,397,755 | 1,824,403 | ||||||
Deferred revenue | 3,137,335 | |||||||
Other long-term liabilities | 45,346 | (3,409,716) | ||||||
Net debt | 3,092,071 | 3,621,733 | ||||||
Cash flow | ||||||||
Cash from operating activities | 98,535 | 147,768 | ||||||
CAPEX | (99,791) | (71,520) | ||||||
Cash from investing activities | 9,396 | (123,761) | ||||||
Cash from financing activities | (129,062) | (37,741) | ||||||
FCF | 7,593,247 | (1,078,447) | ||||||
Balance | ||||||||
Cash | 44,908 | 111,906 | ||||||
Long term investments | 107,546 | 92,580 | ||||||
Excess cash | 59,497 | 122,197 | ||||||
Stockholders' equity | (1,089,129) | 5,793,005 | ||||||
Invested Capital | 5,046,960 | 4,385,350 | ||||||
ROIC | 5.20% | |||||||
ROCE | 6.22% | |||||||
EV | ||||||||
Common stock shares outstanding | 66,047 | 66,212 | ||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | 428,657 | 261,143 | ||||||
EV/EBITDA | ||||||||
Interest | 163,191 | 105,956 | ||||||
Interest/NOPBT | 66.32% |